References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global strategy for the diagnosis, management and prevention of COPD. 2020. https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf
- GINA-GOLD Diagnosis of disease of chronic airflow limitation: asthma, COPD and asthma-COPD overlap syndrome (ACOS ). Available from: https://ginasthma.org/wp-content/uploads/2019/11/GINA_GOLD_ACOS_2014-wms.pdf
- O’Donnell DE , Aaron S , Bourbeau J , et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease 2007 update. Can Respir J. 2007; 14(Suppl B):5B–32B. DOI:10.1155/2007/926421
- Gibson PG , Simpson JL . The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8):728–735. DOI:10.1136/thx.2008.108027
- Nagai A . Guidelines for the diagnosis and management of chronic obstructive pulmonary disease. Nippon Rinsho. 2011;69(10):1729–1734. Oct
- Miravitlles M , Soler-Cataluña JJ , Calle M , et al . Spanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol. 2012;48(7):247–257. DOI:10.1016/j.arbres.2012.04.001
- Koblizek V , Chlumsky J , Zindr V , et al . Chronic Obstructive Pulmonary Disease: Official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157(2):189–201. DOI:10.5507/bp.2013.039
- Kankaanranta H , Harju T , Kilpeläinen M , et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finish guidelines. Basic Clin Pharmacol Toxicol. 2015;116(4):291–307. DOI:10.1111/bcpt.12366
- Barnes PJ . Asthma-COPD overlap. Chest. 2016; 149(1):7–8. DOI:10.1016/j.chest.2015.08.017
- Maselli DJ , Hardin M , Christenson SA , et al. Clinical approach to the therapy of asthma-COPD overlap. Chest. 2019; 155(1):168–177. DOI:10.1016/j.chest.2018.07.028
- Sin DD , Miravitlles M , Mannino DM , et al . What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48(3):664–673. DOI:10.1183/13993003.00436-2016
- Young RP , Hopkins RJ . A new alphabet for COPD care: where "E" stands for España. Eur Respir J. 2017; 49(1):1601970. DOI:10.1183/13993003.01970-2016
- Christenson SA , Steiling K , van den Berge M , et al. Asthma-COPD overlap: clinical relevance of genomic signatures of Type 2 inflammation in COPD. Am J Respir Crit Care Med. 2015;191(7):758–766. DOI:10.1164/rccm.201408-1458OC
- Miravitlles M . Diagnosis of asthma-COPD overlap: the five commandments. Eur Respir J. 2017;49(5):1700506. DOI:10.1183/13993003.00506-2017
- Boulet LP , Boulay MÈ , Dérival JL , et al. Asthma-COPD overlap phenotypes and smoking: comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstruction. COPD. 2018; 15(2):130–138. DOI:10.1080/15412555.2017.1395834
- Perez de Llano L , Cosio BG , Miravitlles M , et al. Accuracy of a new algorithm to identify asthma-COPD overlap (ACO) patients in a cohort of patients with chronic obstructive airway disease. Arch Bronconeumol. 2018;54(4):198–204. DOI:10.1016/j.arbres.2017.10.007
- Soler-Cataluña JJ , Novella L , Soler C , et al. Clinical characteristics and risk of exacerbations associated with different diagnostic criteria of asthma-COPD overlap. Arch Bronconeumol. 2020;56(5):282–290. DOI:10.1016/j.arbres.2019.08.023
- Nuñez A , Sarasate M , Loeb E , et al. Practical guide to the identification and diagnosis of asthma-COPD overlap (ACO). COPD. 2019;16(1):1–7. DOI:10.1080/15412555.2019.1575802
- Hardin M , Cho M , McDonald M-L , et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014;44(2):341–350. DOI:10.1183/09031936.00216013
- Asensio VJ , Tomás A , Iglesias A , et al. Eosinophilic COPD patients display a distinctive serum miRNA profile from asthma and non-eosinophilic COPD. Arch Bronconeumol. 2020;56(4):234–241. DOI:10.1016/j.arbr.2019.09.011
- Iwamoto H , Gao J , Koskela J , et al. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap. Eur Respir J. 2014;43(2):421–429. DOI:10.1183/09031936.00024313
- Gava G , Núñez A , Esquinas C , et al. Analysis of blood biomarkers in patients with chronic obstructive pulmonary disease (COPD) and with asthma-COPD overlap (ACO). COPD. 2020;17(3):306–310. DOI:10.1080/15412555.2020.1761314
- Mostafavi-Pour-Manshadi SMY , Naderi N , Mancino P , et al. Fractional exhaled nitric oxide as an inflammatory biomarker in chronic obstructive pulmonary disease (COPD) with or without concurrent diagnosis of asthma: the Canadian Cohort Obstructive Lung Disease (CanCOLD). COPD. 2020; 17(4):355–365. DOI:10.1080/15412555.2020.1779681
- Ghosh N , Choudhury P , Kaushik SR , et al. Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO). Respir Res. 2020; 21(1):126. DOI:10.1186/s12931-020-01390-4
- Maselli DJ , Hanania NA . Management of asthma COPD overlap. Ann Allergy Asthma Immunol. 2019; 123(4):335–344. DOI:10.1016/j.anai.2019.07.021
- Maltby S , Gibson PG , Powell H , et al. Omalizumab treatment response in a population with severe allergic asthma and overlapping COPD. Chest. 2017; 151(1):78–89. DOI:10.1016/j.chest.2016.09.035
- Peltola L , Heikki P , Harju T . COPD comorbidities predict high mortality – asthma-COPD-overlap has better prognosis. COPD. 2020; 17(4):366–372. DOI:10.1080/15412555.2020.1783647